trial,pubID,pseudogroup,weeks,group,IgD-IgM-/IgA-/IgG+ B cells
G002,G002-852,G002,8,1,934966.0
G002,G002-616,G002,8,1,587483.0
G002,G002-931,G002,8,3,475243.0
G002,G002-577,G002,8,2,486510.0
G002,G002-493,G002,8,2,203525.0
G002,G002-119,G002,8,2,784044.0
G002,G002-758,G002,8,1,459051.0
G002,G002-831,G002,8,2,611010.0
G002,G002-502,G002,8,1,746568.0
G002,G002-293,G002,8,2,375449.0
G002,G002-943,G002,8,2,486625.0
G002,G002-630,G002,8,2,1509732.0
G002,G002-136,G002,8,2,800127.0
G002,G002-341,G002,8,2,356969.0
G002,G002-145,G002,8,2,290056.0
G002,G002-371,G002,8,3,650698.0
G002,G002-820,G002,8,2,1020766.0
G002,G002-997,G002,8,3,299696.0
G002,G002-509,G002,8,1,317208.0
G002,G002-813,G002,8,1,329459.0
G002,G002-988,G002,8,3,585799.0
G002,G002-619,G002,8,1,488156.0
G002,G002-905,G002,8,1,573462.0
G002,G002-304,G002,8,3,118685.0
G002,G002-546,G002,8,1,873675.0
G002,G002-855,G002,8,2,879469.0
G002,G002-516,G002,8,1,644866.0
G002,G002-477,G002,8,3,607382.0
G002,G002-678,G002,8,1,280815.0
G002,G002-884,G002,8,3,554885.0
G002,G002-230,G002,8,2,1943565.0
G002,G002-796,G002,8,3,515313.0
G002,G002-620,G002,8,2,294085.0
G002,G002-595,G002,8,3,257900.0
G002,G002-866,G002,8,3,402506.0
G002,G002-733,G002,8,1,629301.0
G002,G002-871,G002,8,3,417089.0
G002,G002-834,G002,8,1,271728.0
G002,G002-969,G002,8,1,1256684.0
G002,G002-810,G002,8,3,450720.0
G002,G002-427,G002,8,3,265123.0
G002,G002-957,G002,8,2,497804.0
G002,G002-479,G002,8,1,1218468.0
G002,G002-302,G002,8,1,240974.0
G002,G002-632,G002,8,3,88174.0
G002,G002-947,G002,8,2,501637.0
G002,G002-480,G002,8,2,530775.0
G002,G002-462,G002,8,3,97629.0
G002,G002-278,G002,8,3,331863.0
